Transparency of COVID-19 vaccines price
Judgment of the Contentious-Administrative Chamber of the National High Court of 22 December 2023
Capsulas Nº 251
Background The origin of this judgment dates to the request for access to public information regarding the price of the Covid-19 vaccines, the number of doses purchased, and copies of the contracts signed with the supplying pharmaceutical companies. The Ministry of Health granted partial access to the overall data on the number of doses purchased... Read More
El EEDS después del acuerdo político, ¿y ahora qué?
El Global
El pasado 15 de marzo el Parlamento Europeo y el Consejo llegaron a un acuerdo sobre el Espacio Europeo de Datos Sanitarios (EEDS). La fase final de las negociaciones requirió un esfuerzo ímprobo por parte del legislador para alcanzar un compromiso en aspectos tales como qué posibilidades tendrán los ciudadanos de no compartir sus datos... Read More
Faus Moliner participates en “International Comparative Legal Guide – Drug & Medical Device Litigation 2024”
Xavier Moliner and Juan Martínez write the chapter related to Drug & Medical Device Litigation in Spain
INTERNATIONAL COMPARATIVE LEGAL GUIDE
The 2024 edition of the International International Comparative Legal Guide to Drug & Medical Device Litigation magazine is now available. The Guide offers a practical insight into drug and medical devices litigation issues across the world. Xavier Moliner and Juan Martinez were in charge of chapter 15 dedicated to drug and medical device litigation.
Faus Moliner participates in “Chambers Global Practices Guides – Life Sciences 2024”
Juan Martínez, Joan Carles Bailach, Anna Gerbolés and Claudia Gonzalo write the chapter about Spain
Chambers Global Practices Guides
The Life Sciences 2024 guide features over 20 jurisdictions. The guide provides the latest legal information on challenging the decisions of regulatory bodies; clinical trials; the marketing, manufacturing and distribution of pharmaceuticals and medical devices; pricing; digital healthcare; patents; and developments related to COVID-19.
Vientos de cambio en las normas sobre publicidad
El Global
El régimen de la publicidad de medicamentos se encuentra regulado, en cuanto a sus bases, en la normativa europea, concretamente en la Directiva 2001/83/CE en el caso de los medicamentos de uso humano, y en el Reglamento 2019/6, que derogó la antigua Directiva 2001/82/CE, cuando se trata de medicamentos veterinarios. Luego es cada Estado Miembro... Read More
Faus Moliner, ranked in Band 1 for Life Sciences in the Chambers Europe 2024 Guide
Chambers & Partners has published the 2024 edition of the Chambers Europe Guide and Faus Moliner has once again obtained the highest possible recognition.
The Chambers Europe Guide is a prestigious publication. The rankings are the result of extensive research conducted by its in-house research team, which conducts interviews with in-house counsel, other third-party experts and private practice lawyers. The Guide has been publishing independent rankings of law firms for 18 years and Faus Moliner has since the beginning... Read More
Faus & Moliner participates in the “Chambers Global Practices Guides – Pharmaceutical Advertising 2024”
Anna Gerbolés y Laia Rull write the chapter about Law and Practice in Spain
The “Law & Practice” section provides easily accessible information on navigating the legal system when conducting business in the jurisdiction. Leading lawyers explain local law and practice at key transactional stages and for crucial aspects of doing business. The “Trends and Developments” section analizes the latest trends and developments in connection with pharmaceutical advertising in... Read More
Plan Anual Normativo 2024
El Global
El pasado 26 de marzo, el Consejo de Ministros aprobó el Plan Anual Normativo (PAN) del Gobierno para el año 2024. El PAN es un documento que incluye las iniciativas legislativas o reglamentarias que los distintos ministerios prevén elevar durante dicho año natural al Consejo de Ministros para su aprobación, con una descripción breve de... Read More
Faus Moliner is recognized once more in the 2024 Edition of The Legal 500 (Legalease)
Faus Moliner appears in Tier 1 in the area of Healthcare and Life Sciences
This year Jordi Faus is in the Hall of Fame and Xavier Moliner continues to appear as leading individual, while Lluís Alcover has been identified as a key lawyer of our firm. Those interviewed by The Legal 500 highlight that Faus Moliner is “a specialized law firm with which we have collaborated successfully for many... Read More
Faus & Moliner participates in «The Legal 500: Product Liability Country Comparative Guides»
Xavier Moliner and Juan Martínez write the chapter regarding product liability in Spain
The Legal 500 Comparative Guides
The aim of this guide is to provide its readers with a general overview of current Product Liability laws and regulations in each of the jurisdictions to which it refers. Each chapter of this guide provides information about objective product liability, non-contractual and contract liability and litigation that can be raised on these matters. Xavier Moliner... Read More